Versor Investments LP Acquires New Holdings in Privia Health Group, Inc. (NASDAQ:PRVA)

Versor Investments LP acquired a new stake in Privia Health Group, Inc. (NASDAQ:PRVA) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 36,900 shares of the company’s stock, valued at approximately $721,000.

Other large investors have also added to or reduced their stakes in the company. Nordea Investment Management AB raised its holdings in Privia Health Group by 33.1% in the 4th quarter. Nordea Investment Management AB now owns 349,773 shares of the company’s stock valued at $6,953,000 after buying an additional 86,910 shares during the last quarter. Victory Capital Management Inc. raised its holdings in Privia Health Group by 402.9% in the 3rd quarter. Victory Capital Management Inc. now owns 179,049 shares of the company’s stock valued at $3,260,000 after buying an additional 143,446 shares during the last quarter. Franklin Resources Inc. raised its holdings in Privia Health Group by 2.2% in the 3rd quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company’s stock valued at $23,092,000 after buying an additional 28,480 shares during the last quarter. Barclays PLC raised its holdings in Privia Health Group by 240.3% in the 3rd quarter. Barclays PLC now owns 224,018 shares of the company’s stock valued at $4,079,000 after buying an additional 158,188 shares during the last quarter. Finally, JPMorgan Chase & Co. raised its holdings in Privia Health Group by 8.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 188,384 shares of the company’s stock valued at $3,430,000 after buying an additional 14,641 shares during the last quarter. Institutional investors own 94.48% of the company’s stock.

Privia Health Group Stock Down 1.9 %

Shares of PRVA stock opened at $24.97 on Friday. The company has a market cap of $3.00 billion, a price-to-earnings ratio of 249.72, a price-to-earnings-growth ratio of 3.47 and a beta of 0.87. Privia Health Group, Inc. has a 52 week low of $15.92 and a 52 week high of $26.04. The firm has a 50 day moving average of $22.40 and a 200-day moving average of $20.59.

Analyst Upgrades and Downgrades

PRVA has been the subject of a number of recent analyst reports. Barclays increased their target price on shares of Privia Health Group from $19.00 to $21.00 and gave the company an “equal weight” rating in a research report on Friday, November 8th. Stephens reissued an “overweight” rating and set a $26.00 target price on shares of Privia Health Group in a research report on Thursday, January 2nd. JMP Securities reissued a “market outperform” rating and set a $26.00 target price on shares of Privia Health Group in a research report on Friday, February 14th. Needham & Company LLC increased their target price on shares of Privia Health Group from $25.00 to $30.00 and gave the company a “buy” rating in a research report on Friday. Finally, Canaccord Genuity Group increased their target price on shares of Privia Health Group from $29.00 to $30.00 and gave the company a “buy” rating in a research report on Friday. One equities research analyst has rated the stock with a hold rating, fifteen have given a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, Privia Health Group currently has an average rating of “Buy” and an average target price of $26.59.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.